Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats

Journal of Cellular Biochemistry

Volumn 61, Issue 4, 1996, Pages 629-637

  Blair, Harry C ^a,c   Jordan, S Elizabeth ^c   Peterson, T Greg ^b   Barnes, Stephen ^b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

bone resorption; genistein; herbimycin; osteoporosis; tyrphostins

Indexed keywords

DAIDZEIN; GENISTEIN; HERBIMYCIN; ISOFLAVONE DERIVATIVE; PROTEIN TYROSINE KINASE INHIBITOR; TYRPHOSTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE MASS; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FOWL; HEN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

ANIMALS; BENZOQUINONES; BONE RESORPTION; CAFFEIC ACIDS; CELLS, CULTURED; CHICKENS; ENZYME INHIBITORS; FEMALE; FEMUR; GENISTEIN; ISOFLAVONES; LACTAMS, MACROCYCLIC; NITRILES; OSTEOCLASTS; OVARIECTOMY; PROTEIN BIOSYNTHESIS; PROTEIN-TYROSINE KINASES; QUINONES; RATS; TYRPHOSTINS;

EID: 0029945381     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19960616)61:4<629::AID-JCB17>3.0.CO;2-A     Document Type: Article

References (23)

1. Agnusdei D, Camporeale A, Gonnelli S, German C, Baroni MC, Passeri M (1992): Short-term treatment of Paget's disease of bone with ipriflavone. Bone Miner 19:S35-S42.
2. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S-I, Itoh N, Shibuya M, Fukami Y (1987): Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595.
3. Albanese CV, Cudd A, Argentine L, Zambonin-Zallone A, MacIntyre I (1994): Ipriflavone directly inhibits osteoclastic activity. Biochem Biophys Res Commun 199:930-936.
4. American Institute of Nutrition Ad Hoc Committee on Standards for Nutritional Studies (1977): Report of the American Institute of Nutrition Ad Hoc Committee on Standards for Nutritional Studies. J Nutr 107:1340-1348.
5. Barnes S, Kirk M, Coward L (1994): Isoflavones and their conjugates in soy foods: Extraction and analysis by HPLC-mass spectrometry. J Agric Food Chem 42:2464-2474.
6. Benvenuti S, Tanani A, Frediani U, Blanchi S, Masi L, Casano R, Bufalino L, Serio M, Brandi ML (1991): Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line. J Bone Min Res 6:987-996.
7. Blair HC, Kahn AJ, Crouch EC, Jeffrey JJ, Teitelbaum SL (1986): Isolated osteoclasts resorb the organic and inorganic components of bone. J Cell Biol 102:1164-1172.
8. 3H-thymidine incorporation by an osteoblast-like osteosarcoma cell line, UMR106-01. Kidney Int 35:1119-1125.
9. Blair HC, Teitelbaum SL, Tan H-L, Schlesinger PH (1992): Reversible inhibition of osteoclastic activity by bone-bound gallium (III). J Cell Biochem 48:401-410.
10. c-src expression for osteoclasts to form ruffled borders and resorb bone. J Clin Invest 90:1622-1627.
11. Carano A, Teitelbaum SL, Konsek JD, Schlesinger PH, Blair HC (1990): Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest 85:456-461.
12. Draper HH, Sie T-L, Bergan JG (1972): Osteoporosis in aging rats induced by high phosphorous diets. J Nutr 102:1133-1142.
13. Levitzki A (1990): Tyrphostins - Potential antiproliferative agents and novel molecular tools. Biochem Pharmacol 40:913-918.
14. Mazzuoli G, Romagnoli E, Carnevale V, Scarda A, Scarnecchia L, Pacitti MT, Rosso R, Minisola S (1992): Effects of ipriflavone on bone remodeling in primary hyperparathyroidism. Bone Miner 19:S27-S33.
15. Nakamura S, Morimoto S, Takamoto S, Onishi T, Fukuo K, Koh E, Kitano S, Miyashita Y, Yasuda O, Tamatani M, Nakahashi T, Ogihara T (1992): Effect of ipriflavone on bone mineral density and calcium-related factors in elderly females. Calcif Tissue Int 51:S30-S34.
16. Notoya K, Yoshida K, Tsukuda R, Taketomi S (1994): Effect of ipriflavone on expression of markers characteristic of the osteoblast phenotype in rat bone marrow stromal cell culture. J Bone Miner Res 9:395-400.
17. Oursler MJ, Bell LV, Clevinger B, Osdoby P (1985): Identification of osteoclast-specific monoclonal antibodies. J Cell Biol 100:1592-1600.
18. Peterson TG, Barnes S (1991): Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 179:661-667.
19. Soriano P, Montgomery C, Geske R, Bradley A (1991): Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693-702.
20. Teitelbaum SL, Stewart CC, Kahn AJ (1979): Rodent peritoneal macrophages as bone resorbing cells. Calcif Tissue Int 27:255-261.
21. Tsuda M, Kitazaki T, Ito T, Fujita T (1986): The effect of ipriflavone (TC-80) on bone resorption in tissue culture. J Bone Miner Res 1:207-211.
22. Xu X, Wang H-J, Murphy PA, Cook L, Hendrichs L (1994): Dadzein is a more bio-available soy milk isoflavone than is genistein in adult women. J Nutr 124:825-832.
23. c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo. J Clin Invest 91:2791-2795.